Hematopoietic Stem Cell Autografts in Support of Myeloablative Therapy for Multiple Myeloma*

ArticleinJournal of Hematotherapy 3(2):149-53 · February 1994with1 Read
DOI: 10.1089/scd.1.1994.3.149 · Source: PubMed

    Abstract

    This paper reports the experience of a single investigator team on the use of autografting in support of myeloablative therapy for multiple myeloma. This demonstrates continued progress toward decreased morbidity, and virtual elimination of mortality, as a result of rapid hematopoietic recovery, due to the use of peripheral blood stem cell grafts in newly diagnosed patients receiving several non-cross-resistant induction regimens followed by two autologous transplants, complete remission rates in excess of 50% can be achieved. Prognostic factors have also been identified for event-free and overall survival.